Introduction
Periventricular hemorrhagic infarction (PVHI), formerly described as a grade IV germinal matrix hemorrhage (GMH), is seen in approximately 10 to 15% of preterm infants with GMH. 1 It is presumably caused by pressure of the GMH on the periventricular terminal vein that drains the cerebral hemisphere. [2] [3] [4] This leads to venous congestion in the periventricular white matter and subsequently to ischemia and hemorrhage. PVHI, or venous infarction, is now considered as a complication of the GMH instead of an extension of the GMH. 4 Mortality in preterm infants with PVHI has been found to range between 38 and 60%. 1, [5] [6] [7] Surviving preterm infants with PVHI are at high risk for developing cerebral palsy and for an abnormal neurological examination beyond 12 months' adjusted age. [8] [9] [10] [11] Several factors in the perinatal period are associated with PVHI. These include lower gestational age, emergency caesarean section, low Apgar scores, need for respiratory resuscitation, pneumothorax, pulmonary hemorrhage, patent ductus arteriosus, acidosis, and neonatal seizures. 1, 6, 7, 12, 13 It is unknown, within a group of preterm infants with PVHI, which perinatal and neonatal characteristics are associated with mortality and adverse neurological outcome. The aim of this study was therefore to identify perinatal and neonatal risk factors for mortality and adverse neurological outcome at 18 months of age in preterm infants with PVHI.
Functional Development at School Age of Newborn Infants at Risk
Methods

Patients
In a retrospective analysis, we studied infants who had been admitted to the Neonatal Intensive Care Unit (NICU) of the University Medical Center Groningen (UMCG) between 1995 and 2006. We intended to include preterm infants (gestational age < 37 weeks) with PVHI diagnosed by cranial ultrasonography. To this end we searched the patient database (which contains all diagnoses of every infant admitted to the NICU) on infants diagnosed with PVHI, venous infarction, GMH grade IV and parenchymal cerebral bleeding. We excluded patients with major chromosomal and congenital abnormalities.
Cranial Ultrasonography Classification
According to the routine scanning protocol of our unit, the first ultrasound scan was made within 72 hours after birth and then at a minimum of weekly intervals until stabilization or the disappearance of any abnormality. The scans were performed by means of real-time mechanical sector scanners equipped with a 7.5
MHz transducer.
All infants admitted to our NICU are subjected to the scanning protocol, if they match one of the following criteria: gestational age < 35 weeks, birth weight < 1500 grams, complicated delivery with a risk for brain injury, perinatal asphyxia, and suspected congenital cerebral malformation.
Three experts (AFB, JK, HTH) reviewed the serial ultrasound scans of the infants who were included after the patient database search, to determine whether PVHI was present or not. The experts were blind as to the infants' outcome. The final study group was defined after this review.
We scored several characteristics of the PVHI. These included unilateral or bilateral infarction, left or right-sided infarction, localization and extension of the infarction (frontal, parietal, occipital or combinations) and residual abnormalities (e.g. porencephalic cysts). When bilateral, the localization and extension were based on the side that was affected most. Next we scored additional cerebral abnormalities.
These included grade of GMH (grades I, II or III), 14 unilateral or bilateral GMH, presence or emergence of posthemorrhagic ventricular dilatation (PHVD) and cystic periventricular leukomalacia (PVL). PHVD was defined as a lateral ventricle size of more than 0.33 according to Evans' index (the right and left lateral horn width divided by the maximum internal skull width). 15 Cystic periventricular leukomalacia was classified as stage 2 or worse, according to de Vries et al. 16 When the experts disagreed, the scans involved were re-evaluated by all experts, together. In all cases a consensus was reached on a final score.
Perinatal Risk Factors
We reviewed the medical charts of the infants for perinatal and neonatal risk 19 In case of cerebral palsy, gross motor functioning was scored by a physiatrist using the Gross Motor Function Classification System (GMFCS). 20 This is a functional, To investigate whether the outcome of preterm infants with PVHI at our NICU changed over time we studied mortality rate, development of cerebral palsy, and GMFCS throughout the study period.
Statistical Analysis
We calculated odds ratios by univariate logistic regression to determine which perinatal and neonatal factors and which cerebral characteristics were related to mortality. We repeated these calculations in the survivors for the development of cerebral palsy. We used chi 2 for trend to relate the severity of cerebral palsy to the risk factors and cerebral characteristics, and to calculate the changes in outcome throughout the study period. Finally, we used backward multivariate logistic regression analysis to determine which risk factors detected by the univariate analyses (with p<.10) had independent prognostic value for outcome. Throughout the analyses p<.05 was considered to be statistically significant. SPSS software for Windows, version 14.0 (SPSS Inc. Chicago, Illinois) was used for all analyses.
Results
Between 1995 and 2006, 4022 patients with a gestational age of < 37 weeks were admitted to our NICU. After database search, 66 infants were selected with (suspected) intraparenchymal hemorrhages. After reviewing the cranial ultrasound scans, 54 infants with periventricular hemorrhagic infarctions were included in the study. This is 1.3% of all infants (gestational age < 37 weeks) admitted to the NICU during the study period. Table 1 gives an overview of the patient demographics.
The PVHI was unilateral in 45 infants (83%): left-sided in 26 (48%), right-sided in 19 (35%). Nine infants (17%) had bilateral PVHI. The PVHI was localized to the frontoparietal region in 14 infants (26%), to the parieto-occipital region in 25 infants (46%) and extended throughout the entire periventricular region (fronto-parietooccipital) in 15 infants (28%). In 37 infants (69%) the PVHI was associated with a GMH grades I or II; in 17 infants (31%) with a GMH grade III. Sixteen infants (30%)
developed PHVD. Seven of them did not need drainage of cerebrospinal fluid, five needed a temporary ventricular drain and four required a permanent shunt.
Bilateral subtle echodensities, not related to the PVHI, developed into cystic PVL in two infants (4%).
Mortality
Of the 54 infants, 16 died (30%). Fourteen infants died despite optimal treatment.
In six infants the cause of death was respiratory failure and five infants died of combined respiratory and circulatory failure. One infant died because of a necrotizing enterocolitis, one because of a late onset sepsis and one because of extensive bilateral hemorrhage with a persistent flat trace EEG. Two infants died after life support was withdrawn. In both cases the prognosis was considered to be poor, based on the combination of severe respiratory and neurological signs. Table 2 gives an overview of the perinatal and neonatal factors associated with mortality. A lower gestational age, signs of circulatory failure (use of inotropics and metabolic acidosis), maternal intrauterine infection and neonatal seizures were associated with increased mortality. Table 3 gives an overview of the characteristics of the PVHI and additional cerebral abnormalities in relation to mortality. Localization and extension of the PVHI were not associated with death or survival. Only three infants had PVHI limited to the frontal region and all three survived. Of additional cerebral abnormalities, GMH grade III was present more frequently in infants who died than in survivors. As a consequence, GMH grades I
and II were present more frequently in survivors.
Neurological Outcome
Of the 38 surviving children, 13 (34%) were normal and 25 (66%) had developed cerebral palsy. Four infants (11%) had cerebral palsy with moderate to severe functional limitations, GMFCS levels III (n=1) and IV (n=3). These four infants all had bilateral cerebral palsy. Twenty one infants (55%) had mild, unilateral cerebral palsy, GMFCS levels I (n=10) and II (n=11). Table 4 gives an overview of the cerebral characteristics on ultrasound in relation to the development of cerebral palsy and GMFCS levels. All children with extensive PVHI (fronto-parieto-occipital, n=8) developed cerebral palsy, with GMFCS levels I or II (OR > 4.7 p=.04). We could not identify any other localization of the PVHI that correlated with the development and severity of cerebral palsy. Concerning additional cerebral abnormalities, GMH grade III was associated with higher GMFCS levels, thus with more severe cerebral palsy. Only four infants had GMFCS levels III or IV. In two of them bilateral cystic PVL (and GMH grade III) was present, in the other two we could not identify any reason why these infants in particular developed a more severe cerebral palsy.
Perinatal and neonatal factors (including late onset morbidity) did not correlate with the development and severity of cerebral palsy, only intrauterine growth restriction nearly reached significance (p=.06). Of the survivors, two children were born after intrauterine growth restriction; one had GMFCS level II and one level IV.
Trends in Outcome over Time
Mortality decreased from 1995 to 2006 (p=.03). In addition, the incidence of cerebral palsy in surviving children also decreased (p=.01). The severity of cerebral palsy, measured by the GMFCS level, did not change during the study period.
Multivariate Logistic Regression Analysis
Since the clinical and cerebral characteristics are likely to be interdependent, we IUGR (<P10) n=4 (7) Maternal intrauterine infection 1 n=11 (20) Early onset sepsis n=7 (13) Asphyxia Resuscitation 2 n=2 (4) Apgar at 1' 4 (1) (2) (3) (4) (5) (6) (7) (8) (9) Apgar at 5' 8 (2) (3) (4) (5) (6) (7) (8) (9) (10) Umbilical cord pH 7.21 (6. Pneumothorax n=9 (17) Respiratory acidosis n=14 (26) Circulatory failure Inotropics n=27 (50) Metabolic acidosis n=10 (19) Neonatal seizures n=13 (24) Mortality n=16 (30) Age of death 5.5 days Late neonatal morbidity ROP (grade I-II vs. grade III-V) 11 (20) vs. 2 (5) Late onset sepsis 14 (26) Necrotizing enterocolitis 3 (6) Bronchopulmonary dysplasia 14 (26) Data are given as median (minimum-maximum) or numbers (percentage). 
Maternal intrauterine infection was scored by clinical signs as fetal tachycardia and maternal fever (>38°C), often combined with the use of maternal antibiotics 2. Resuscitation was scored in case of external heart massage and/or use of epinephrine
Abbreviations: IUGR, intrauterine growth restriction; IPPV, intermittent positive pressure ventilation; HFO, high frequency oscillation; ROP, retinopathy of prematurity
Discussion
We identified several risk factors predictive for mortality and adverse neurological outcome at 18 months of age in preterm infants with PVHI. A low gestational age, neonatal seizures, signs of circulatory failure (use of inotropics and metabolic acidosis), maternal intrauterine infection and an associated GMH grade III were related to mortality. Independent predictors were circulatory failure and maternal intrauterine infection. Sixty six percent of the survivors developed cerebral palsy.
Only the most extended PVHI (fronto-parieto-occipital) was associated with the development of cerebral palsy. Characteristics of the PVHI (localization and extension) were not related to the severity of cerebral palsy. However, additional cerebral abnormalities such as GMH grade III and cystic PVL were associated with more severe cerebral palsy.
We found a lower mortality (30%) compared to previous studies, which reported percentages from 38 to 60%. 1, [5] [6] [7] 21 It is striking that in our study the extension of the PVHI was not related to mortality. This association was reported by Guzzetta et al. in 19865 and recently by Bassan et al. 22 An explanation for the difference might be the characteristics of the study groups. Both studies reported a higher percentage of infants with extended lesions (50-66%) than the present study (28%). The percentage of infants with associated GMH grade III in these studies was also much higher (80-88% versus 31%). 5, 22 This suggests that morbidity of the infants in the present study might have been less severe than in these previous studies. Advances in neonatal care, better imaging techniques and decisions regarding withdrawal of life support might also have influenced the association. 22 In the present study, most of the infants who died had suffered respiratory or circulatory failure, unresponsive to treatment.
We found that mortality in infants with PVHI was associated with low gestational age, maternal intrauterine infections, signs of circulatory failure, an associated GMH grade III and neonatal seizures. After multivariate logistic regression analysis, only circulatory failure (use of inotropics) and signs of maternal intrauterine infection were independent predictors for mortality. Circulatory failure, leading to disturbances of systemic and cerebral hemodynamics, is identified as a risk factor for the emergence of PVHI in several studies. 7, 12, 13 Apparently, this factor is associated not only with the emergence of PVHI but also with a considerably increased risk of dying (OR 31.2) in case of PVHI. The association of mortality with maternal intrauterine infections in the present study was less strong and just reached significance. Intrauterine (perinatal) infections and inflammation have been associated in particular with periventricular leukomalacia 23 and not with PVHI. 13, 24 However, other larger studies have demonstrated that intrauterine infections, chorio-amnionitis, placental inflammation and early sepsis are associated with GMH grade III and PVHI. [25] [26] [27] Although the percentage of infants with signs of maternal intrauterine infection was low in the present study, our data suggest that its presence increases the risk of dying.
Neurological outcome at the age of 18 months was normal in 34% of the survivors.
The remaining infants developed cerebral palsy, which was mild in most cases.
The percentage of infants developing cerebral palsy after PVHI in the present study was similar to previous studies, ranging from 60 to 90%. 1, 5, 8, 9, 11, 22 Of all cerebral characteristics investigated, only the most extended localization (frontoparieto-occipital) was associated with the development of cerebral palsy. This was also found by Bassan et al. 22 There is controversy about anterior frontal lesions.
Rademaker et al. demonstrated in a small study of 20 infants that a localization of PVHI in the occipital region was associated with the development of cerebral palsy. 8 A localization more frontally, anterior of the trigonum, was associated with a normal outcome. 8 Bassan et al. found the opposite, i.e. anterior frontal involvement of the PVHI was associated with an abnormal neuromotor examination at the age of 1 year. 22 We could not confirm any of these results. In our study, we found that some infants with frontal, frontoparietal and parieto-occipital lesions developed cerebral palsy, but others did not. Concerning perinatal and neonatal risk factors, no associations existed with the development of cerebral palsy.
Functional limitations in children developing cerebral palsy were mostly mild, with GMFCS levels I and II. Only a few infants had cerebral palsy with more severe functional limitations. This was associated with additional cerebral abnormalities, such as cystic PVL and an associated GMH grade III. It is known that cystic PVL causes more severe neurological sequelae than PVHI. 1, 11, 28 To our surprise, GMFCS levels were not related to localization and extension of the PVHI, nor to any other perinatal or neonatal risk factor. Other studies in infants with PVHI and functional outcomes are scarce and do not report about outcomes of the infants in terms of functional abilities and limitations.
As a retrospective analysis, the present study is subject to potential limitations.
We took care to include all children with PVHI, but perhaps we still missed some.
Being a single-center study, caution should be taken to generalize our results to other centers. Perinatal and neonatal care has changed considerably during the long range of years covered by this study (1995) (1996) (1997) (1998) (1999) (2000) (2001) (2002) (2003) (2004) (2005) (2006) . During the last 20 years, the incidence of severe intracranial hemorrhages has declined rapidly. 26 Factors that were risk factors in the past are not necessarily risk factors at present.
We did not confirm the PVHI on cranial ultrasound scans using magnetic resonance imaging in all infants. We are confident however, that we could reliably make the diagnosis of PVHI by cranial ultrasonography alone. Earlier studies comparing magnetic resonance imaging with cranial ultrasonography in PVHI showed that ultrasonography is a reliable method for diagnosing PVHI. 1, 10 The distinction between bilateral PVHI and cystic PVL is sometimes difficult to make. 1, 10 We used the criteria mentioned in De Vries et al. 1 to differentiate between the two types of brain lesions. In our opinion, we could reliably make this distinction because ultrasound scans were performed at least at weekly intervals. Only two infants had both PVHI and cystic PVL. This incidence is similar to other studies. 1, 10 All surviving children were examined at follow-up at a minimum of 18 months' corrected age. We realize that 18 months is a bit young to determine the GMFCS level reliably. It is known that the GMFCS is a rather stable measure from the age of two onwards. 29 In the present study, most children had already turned two. With this in mind, the GMFCS levels in the majority of the infants who had developed cerebral palsy would remain low, indicating rather good gross motor functioning.
Conclusion
We identified several risk factors predictive for mortality and adverse neurological outcome at 18 months of age in preterm infants with PVHI. Thirty percent of the infants died, mostly with respiratory and/or circulatory failure, unresponsive to treatment.
Circulatory failure and maternal intrauterine infection, but not characteristics of the PVHI, were independently predictive for mortality. Sixty six percent of the survivors developed cerebral palsy, which was mild in most cases. Only the most extended PVHI (fronto-parieto-occipital) was associated with the development of cerebral palsy. Characteristics of the PVHI (localization and extension) were not related to the severity of cerebral palsy, but the presence of concurrent GMH grade III and cystic PVL were associated with more severe cerebral palsy.
